DODION PIERRE F 4
4 · ARIAD PHARMACEUTICALS INC · Filed Apr 3, 2013
Insider Transaction Report
Form 4
DODION PIERRE F
Senior VP, Chief Medical Off
Transactions
- Exercise/Conversion
Restricted Stock Units
2013-04-01−6,000→ 0 total→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2013-04-01+6,000→ 60,082 total - Sale
Common Stock
2013-04-02$18.04/sh−2,400$43,295→ 57,682 total
Footnotes (4)
- [F1]Shares were acquired upon vesting of restricted stock units awarded on April 1, 2011.
- [F2]Represents shares withheld to satisfy withholding tax requirements.
- [F3]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- [F4]The restricted stock units vested on April 1, 2013.